Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.0530
-0.0010 (-1.85%)
Aug 21, 2026, 4:10 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 78.11 million as of August 21, 2026. Its market cap has decreased by -78.28% in one year.
Market Cap
78.11M
Enterprise Value
-19.81M
Revenue
7.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 78.11M, an increase of 2,032.35%. That is a compound annual growth rate of 10.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 78.11M | -87.23% |
| Dec 31, 2025 | 611.59M | 15.11% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 112.30M |
| Alterity Therapeutics | 106.58M |
| Paradigm Biopharmaceuticals | 103.95M |
| LTR Pharma | 89.98M |
| Avecho Biotechnology | 81.14M |
| Prescient Therapeutics | 80.97M |
| Arovella Therapeutics | 77.36M |
| Amplia Therapeutics | 77.00M |